Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

3 Resultados de la búsqueda.

Pharmacokinetics of Degarelix in Prostate Cancer NCT02468284 - Eligibility Criteria

- 22/5/19 - 1 formulario, 2 itemgroups, 9 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Open-label, Multi-Centre Trial Investigating Pharmacokinetics of Degarelix After a Starting Dose of 240 mg (40 mg/mL) Followed by Six Maintenance Doses of 80 mg (20 mg/mL) in Chinese Patients With Prostate Cancer Requiring Androgen Deprivation Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT02468284

Lu PSMA-Studie Prostatakarzinom NCT0000001

- 8/7/16 - 1 formulario, 9 itemgroups, 21 items, 2 idiomas

Itemgroups: Identificaton, Session 1, Session 2, Session 3, Session 4, Session 5, Session 6, Session 7, Session 8

Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: Lu PSMA

CTC PSMA-Studie Prostatakarzinom NCT0000001

- 8/7/16 - 1 formulario, 9 itemgroups, 101 items, 2 idiomas

Itemgroups: Baseline, 1st Cycle, 2nd Cycle, 3rd Cycle, 4th Cycle, 5th Cycle, 6th Cycle, 7th Cycle, 8th Cycle

Quelle: PSMA-Studie Prostatakarzinom PD Dr. med. Kambiz Rahbar UKM, Nuklearmedizin Teil: CTC

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial

Palabras clave

Tabla de contenido

Modelos de datos seleccionados

Pharmacokinetics of Degarelix in Prostate Cancer NCT02468284 - Eligibility Criteria

Lu PSMA-Studie Prostatakarzinom NCT0000001

CTC PSMA-Studie Prostatakarzinom NCT0000001

Palabras clave

Tabla de contenido

Modelos de datos seleccionados

Pharmacokinetics of Degarelix in Prostate Cancer NCT02468284 - Eligibility Criteria

Lu PSMA-Studie Prostatakarzinom NCT0000001

CTC PSMA-Studie Prostatakarzinom NCT0000001

Contacto

Ayuda